ACP3 and neoplasm: For translational relevance, ACPP-MMAE and CDX3379-MMAE share identical drug-linker chemistry of clinical ADCs carrying MMAE (i.e. brentuximab-vedotin, enfortumab-vedotin and tisotumab-vedotin) and only vary in how MMAE is tumor-targeted25,29,30.